
Nvixo S 250mg/125mg Injection
Marketer
Vinsha Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Nvixo S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation. Administer this injection only as directed by a medical professional; strictly adhere to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption may increase drowsiness. While generally not impairing driving ability, avoid driving if experiencing dizziness or somnolence. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Nvixo S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Nvixo S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Nvixo S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Nvixo S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nvixo S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Nvixo S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Nvixo S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Nvixo S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Nvixo S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Nvixo S 250mg/125mg Injection may induce drowsiness, visual disturbances, or dizziness. Operation of a motor vehicle should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Nvixo S 250mg/125mg Injection use in individuals with renal impairment is scarce. Seek medical advice.
LiverCAUTION
Administering Nvixo S 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Nvixo S 250mg/125mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Nvixo S 250mg/125mg Injection :
Should you forget a scheduled dose of Nvixo S 250mg/125mg Injection, seek medical advice.
Facts to Know About Nvixo S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
